¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary familial xanthomatosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cerebrotendinous xanthomatosis
    ³úÈûÁÙȲ»öÁ¾Áõ
  • xanthomatosis
    Ȳ»öÁ¾Áõ
  • acholuric familial jaundice
    ¹«´ãÁó´¢°¡Á·¼ºÈ²´Þ
  • familial
    °¡Á·(¼º)-
  • familial adenomatous polyposis
    °¡Á·¼º»ùÁ¾Æú¸³Áõ
  • familial aminoglycoside ototoxicity
    °¡Á·¼º¾Æ¹Ì³ë±Û¸®Äڽõå±Íµ¶¼º
  • familial amyloid neuropathy
    °¡Á·¼º¾Æ¹Ð·ÎÀ̵å½Å°æº´(Áõ)
  • familial annulare erythema
    °¡Á·¼ºÀ±»óÈ«¹Ý, °¡Á·¼º°í¸®È«¹Ý
  • familial cardiomyopathy
    °¡Á·¼º½ÉÀå±ÙÀ°º´(Áõ), °¡Á·¼º½É±Ùº´(Áõ)
  • familial dysautonomia
    °¡Á·¼ºÀÚÀ²½Å°æÀÌ»ó(Áõ)
  • familial goiter
    °¡Á·¼º°©»ó»ùÁ¾
  • familial hemophagocytic lymphohistiocytosis
    °¡Á·¼ºÀûÇ÷±¸Æ÷½Ä¼º¸²ÇÁÁ¶Á÷±¸Áõ½ÄÁõ
  • familial paroxysmal polyserositis
    °¡Á·¼º¹ßÀÛ´Ù¹ßÀ帷¿°
  • familial polyposis
    °¡Á·¼ºÆú¸³Áõ
  • familial progressive hearing loss
    °¡Á·¼ºÁøÇ೭û
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial adenomatous polyposis
    °¡Á·¼ºÅ«Ã¢ÀÚÆú¸³Áõ, °¡Á·¼º´ëÀåÆú¸³Áõ
  • xanthomatosis
    Ȳ»öÁ¾Áõ
  • primary aldosteronism
    ÀÏÂ÷¾Ëµµ½ºÅ×·ÐÁõ
  • primary cancer
    ¿ø¹ß¾Ï
  • primary constriction
    (¢¡centromere) ¸Åµì, µ¿¿øÃ¼, Áß½ÉÀý
  • primary health care
    ÀÏÂ÷º¸°ÇÀÇ·á
  • primary cholestatic liver disease
    ÀÏÂ÷¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ÀÏÂ÷´ãÁóÁ¤Ã¼°£Áúȯ
  • primary irritant dermatitis
    ¿ø¹ßÀÚ±ØÇǺο°
  • primary infection
    ÀÏÂ÷°¨¿°
  • primary
    ¿ø¹ß-, ÀÏÂ÷-
  • primary polydipsia
    ¿ø¹ß¼º´ÙÀ½Áõ, ÀÏÂ÷Àû´ÙÀ½Áõ, ¿ø¹ß¼º´ÙÀ½´Ù°¥Áõ, ÀÏÂ÷Àû´ÙÀ½´Ù°¥Áõ
  • spontaneous primary peritonitis
    ¿ø¹ßº¹¸·¿°, ÀÏÂ÷º¹¸·¿°, ¿ø¹ß¹è¸·¿°, ÀÏÂ÷¹è¸·¿°
  • primary stage
    Ãʱâ
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cerebrotendinous xanthomatosis
    ³úÈûÁÙȲ»öÁ¾Áõ
  • generalized plane xanthomatosis
    Àü½ÅÆíÆòȲ»öÁ¾Áõ
  • tuberous xanthomatosis
    °áÀýȲ»öÁ¾Áõ
  • xanthomatosis
    Ȳ»öÁ¾Áõ
  • acholuric familial jaundice
    (¢¡hereditary spherocytosis) À¯ÀüµÕ±ÙÀûÇ÷±¸Áõ, À¯Àü±¸ÇüÀûÇ÷±¸
  • familial cardiomyopathy
    °¡Á·½ÉÀå±ÙÀ°º´Áõ
  • familial dyskeratotic comedo
    °¡Á·°¢È­ÀÌ»ó¸éÆ÷
  • familial dysautonomia
    °¡Á·ÀÚÀ²½Å°æ±â´ÉÀÌ»ó
  • endogenous familial hypertriglyceridemia
    ³»Àΰ¡Á·°íÁß¼ºÁö¹æÇ÷Áõ
  • familial eosinophilia
    °¡Á·È£»ê±¸Áõ°¡Áõ
  • familial annulare erythema
    °¡Á·À±»óÈ«¹Ý, °¡Á·°í¸®È«¹Ý
  • familial pigmented purpuric eruption
    °¡Á·»ö¼ÒÀڹݹßÁø
  • familial
    °¡Á·-
  • familial hyperlipoproteinemia
    °¡Á·°íÁö¹æ´Ü¹éÇ÷Áõ
  • familial hyperuricemia
    °¡Á·°í´¢»êÇ÷Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • generalized plane xanthomatosis
    Àü½Å¼º ÆíÆò Ȳ»öÁ¾Áõ
  • Familial hypercholesterolemia
    °¡Á·¼º(Ê«ðéàõ) °í(ÍÔ)ÄÝ·¹½ºÅ×·ÑÇ÷Áõ(úìñø)
  • Hailey-Hailey disease = familial benign chronic pemphigus
    ÇìÀϸ®-ÇìÀϸ®º´
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼ºÈæ¾Ï½Ã¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼º Èæ³»Àå ¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • hearing loss, familial pregressive
    °¡Á· ÁøÇà(¼º) ³­Ã»
  • hyperbilirubinemia,asymptomatric familial
    ¹«ÁõÈÄ °¡Á·¼º(Ùíñøý¦ Ê«ðéàõ)
  • hypercholesterolemia,familial
    °¡Á·¼º(Ê«ðéàõ)
  • idiopathic familial fibromatosis
    Ư¹ß¼º °¡Á·¼º ¼¶À¯Á¾Áõ.
  • idiopathic familial fibromatosis
    Ư¹ß¼º °¡Á·¼º ¼¶À¯Á¾Áõ
  • infantile amaurotic familial idiocy
    ¿µ¾Æ¼º Èæ³»À强 °¡Á·¼º ¹éÄ¡.
  • infantile amaurotic familial idiocy
    ¿µ¾Æ¼º Èæ³»À强 °¡Á·¼º ¹éÄ¡.
  • primary yolk sac [primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac [primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • Ghon s primary complex
    °ï¿ø¹ßÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cerebrotendinous xanthomatosis
    ³ú°Ç¼º Ȳ»öÁ¾Áõ(ÒàËòàõüÜßäðþñø).
  • cerebrotendinous xanthomatosis
    ³ú°Ç¼º Ȳ»öÁ¾Áõ
  • cerebrotendinous xanthomatosis
    ´ë³ú°Ç Ȳ»öÁ¾Áõ
  • generalized plane xanthomatosis
    Àü½Å¼º ÆíÆò Ȳ»öÁ¾Áõ
  • tuberous xanthomatosis
    °áÀý¼º Ȳ»öÁ¾Áõ(Ì¿ï½àõüÜßäðþñø)
  • xanthomatosis
    Ȳ»öÁ¾Áõ(üÜßäðþñø)
  • primary yolk sac [primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac [primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac[primary vitelline sac]
  • primary yolk sac[primary vitelline sac]
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼º Èæ³»Àå ¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼ºÈæ¾Ï½Ã¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • benign familial pemphigus
    ¾ç¼º °¡Á·¼º(åÐàõ Ê«ðéàõ) õÆ÷â(ô¸øÞóê)
  • breast/ovarian familial cancer syndrome
    À¯¹æ/³­¼Ò °¡Á·¼º ¾ÏÁõÈıº
  • chronic familial jaundice
    ¸¸¼º°¡Á·¼º Ȳ´Þ(¡­Ê«ðéàõüÜÓ¸).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Primary yolk sac [Primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷³­È²³¶
  • Primary yolk sac [Primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷³­È²³¶
  • Diploid primary gametocyte
    µÎ¹è¼öüÀÏÂ÷»ý½Ä¼¼Æ÷
    [¿¾ ¿ë¾î] ¹è¼öüÁ¦ÀÏ»ý½Ä¼¼Æ÷
  • Reticulofibrous membranous bone [Primary membranous bone]
    ¼¼¸Á¼¶À¯¸·»À [ÀÏÂ÷¸·»À]
    [¿¾ ¿ë¾î] ÀÏÂ÷¸·¼º°ñ
  • Premaxilla (Primary palate)
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] ¾ÇÀü±¸°³
  • Premaxilla [Primary palate]
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] Àü»ó¾Ç°ñ
  • Primary vitelline sac
    ¿ø½Ã³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ¿ø½Ã³­È²³¶
  • Primary amnion
    ¿ø½Ã¾ç¸·
    [¿¾ ¿ë¾î] ¿ø½Ã¾ç¸·
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£[ÀÏÂ÷»À¼ÓÁú°ø°£]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary polar body
    ÀÏÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • Primary bronchus
    ÀÏÂ÷±â°üÁö
    [¿¾ ¿ë¾î] ¿ø½Ã±â°üÁö
  • Primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­¸ð¼¼Æ÷
  • Primary follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ¿ø½Ã³­Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial aggregation
    °¡Á·ÁýÀû¼º
  • primary amebic meningoencephalitis
    ¿ø¹ß¼º¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • primary infection
    ÀÏÂ÷°¨¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • familial hypercholesterolemia
    °¡Á·¼º(Ê«ðéàõ) °ú(Φ)ÄÝ·¹½ºÅ×·ÑÇ÷Áõ(úìñø)
  • familial lysosomal lipase deficiency
    °¡Á·¼º(Ê«ðéàõ) ¶óÀÌ¼Ò¼Ø ¶óÀÌÆäÀ̽º °áÇÌ(ÌÀù¹)
  • familial methemoglobinemia
    °¡Á·¼º(Ê«ðéàõ) ¸ÞÅ׸ð±Û·ÎºóÇ÷Áõ(úìñø)
  • primary acidosis
    ¿ø¹ß¼º »êÁõ(ê«Û¡àõß«ñø)
  • primary active transport
    ÀÏÂ÷ ´Éµ¿¼ö¼Û(ìéó­ÒöÔÑâÃáê)
  • primary alkali deficit
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°áÇÌ(ÌÀù¹)
  • primary alkali excess
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°úÀ×(Φí¥)
  • primary alkalosis
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®Áõ(ñø)
  • primary amino acid
    ÀÏÂ÷(ìéó­) ¾Æ¹Ì³ë»ê(ß«)
  • primary bile acid
    ÀÏÂ÷ ´ãÁó»ê(ìéó­ÓÅñðß«)
  • primary carbon dioxide deficit
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò °áÇÌ(ê«Û¡àõì£ß«ûù÷©áÈÌÀù¹)
  • primary carbon dioxide excess
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò(ê´Û¡àõ ì£ß«ûù÷©áÈ) °úÀ×(Φí¥)
  • primary charge effect
    ÀÏÂ÷ ÀüÇÏÈ¿°ú(ìéó­ï³ùÃüùÍý)
  • primary culture
    ÀÏÂ÷ ¹è¾ç(ìéó­ÛÆå×)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • xanthomatosis
    Ȳ»öÁ¾Áõ
  • familial
    °¡Á·¼ºÀÇ
  • familial polyposis
    °¡Á·¼ºÆú¸³Áõ
  • primary
    ÀÏÂ÷(¼º)ÀÇ, Á¦ÀÏÀÇ, ÃʱâÀÇ, ¿ø¹ß(¼º)ÀÇ
  • primary amenorrhea
    ¿ø¹ß(¼º)¹«¿ù°æ
  • primary cancer
    ¿ø¹ß¾Ï
  • primary complex
    Ãʱ⺯ȭ±º
  • primary hypertension
    ¿ø¹ß(¼º)°íÇ÷¾ÐÁõ
  • primary infection
    ÀÏÂ÷°¨¿°
  • primary infiltration
    ÃʱâħÀ±
  • primary lesion
    ÀÏÂ÷¼ºº´º¯, Ãʰ¨¿°¼Ò
  • primary lobule
    ÀÏÂ÷¼Ò¿±
  • primary ossification center
    ÀÏÂ÷°ñÈ­Áß½É
  • primary ray
    ÀÏÂ÷¼±
  • primary tuberculosis
    ÀÏÂ÷°áÇÙ(Áõ), Ãʱâ°áÇÙ(Áõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CTX cefotaxime; cerebrotendinous xanthomatosis; chemotaxis; clinical trials exemption scheme; costotendi...
Xanth xanthomatosis
DEF decayed primary teeth requiring filling, decayed primary teeth requiring extraction, and primary tee...
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CTX Cerebrotendinous Xanthomatosis
primary SS Primary Sjogren's syndrome
BFNC Benign Familial Neonatal Convulsions
FAD Familial Alzheimer's disease
FALS Familial ALS
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • xanthomatosis
    Ȳ»öÁ¾Áõ
    Áö¹æ ´ë»ç Àå¾Ö·Î ÀÎÇÏ¿© ü³»¿¡ °úµµÇÑ Áö¹æÀÌ ÃàÀûµÈ »óÅ·μ­ ÇǺΠº´¼Ò¿¡ Æ÷¸» ¼¼Æ÷°¡ º¸ÀÌ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • primary vaccination :

    primary's area

    Á¦1¿µ¿ª
    ¿îµ¿°ú °¨°¢ºÎ¸¦ Æ÷ÇÔÇÏ´Â ´ë³ú ÇÇÁú ¿µ¿ª.
  • amaurotic familial idiocy
    °¡Á·¼º Èæ³»Àå ¹éÄ¡
    µ¿ÀǾî=Tay-Sach's disease.
  • asymptomatric familial hyperbilirubinemia
    ¹«ÁõÈÄ °¡Á·¼º °úºô¸®·çºóÇ÷Áõ
  • benign familial pemphigus
    ¾ç¼º °¡Á·¼º õÆ÷â
    µå¹°°Ô ¹ß»ýÇÏ´Â, À¯Àü¼ºÀ̸ç Áö¼ÓÀûÀ¸·Î Àç¹ßÀ» ¹Ýº¹ÇÏ´Â ¼ÒÆ÷¼º ¹× ÀÛÀº ¼öÆ÷¼º ÇǺο°À¸·Î, ¾×¿Í, ¼­ÇýºÎ ¹× ¸ñ ºÎÀ§¸¦ °¡Àå Àß Ä§¹üÇÏÁö¸¸, ¶§·Î´Â ±¤¹üÇÑ ºÎÀ§¸¦ ħ¹üÇÑ´Ù. º´º¯Àº ´Ù¹ß¼ºÀ̸ç, ¼öÁÖÀÏ ³»Áö ¼ö°³¿ù ÈÄ¿¡ ¼èÅðÇÑ´Ù. ÀÌ ÁúȯÀº »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÑ´Ù.
  • familial adenomatous polyposis
    °¡Á·¼º ¼±Á¾¼º ¿ëÁ¾Áõ
  • familial amyloid polyneuropathy
    °¡Á·¼º ¾Æ¹Ð·ÎÀÌµå ´Ù¹ß ½Å°æº´Áõ
  • familial benign chronic pemphigus
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â
  • familial cold urticaria
    °¡Á·¼º Çѳà µÎµå·¯±â
  • familial cutaneous collagenosis
    °¡Á·¼º ÇǺΠ±³¿øÁõ
  • familial dysbetalipoproteinemia
    °¡Á·¼º ÀÌ»ó º£Å¸ ¸®Æ÷ ÇÁ·ÎÅ×ÀÎ Ç÷Áõ
  • familial fibrous dysplasia
    °¡Á·¼º ¼¶À¯ ÀÌÇü¼º
  • familial genuine malfomation of root
    °¡Á·¼º ¼±Ãµ¼º Ä¡±Ù ±âÇü
    µ¿ÀǾî=dentinal dys
  • familial hemolytic anemia
    °¡Á·¼º ¿ëÇ÷¼º ºóÇ÷
  • familial histocytic dermatoarthritis
    °¡Á·¼º Á¶Á÷±¸¼º ÇǺΠ°üÀý¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
familial hypercholesteraemic xanthomatosis Hyperlipoproteinaemia characterised by increased plasma levels of beta-lipoproteins, cholesterol, and phospholipids, but normal triglycerides; heterozygotes have mild lipid changes and are susceptible to atherosclerosis in middle age, but homozygotes have severe changes often with generalised xanthomatosis and xanthelasma, and frank clinical atherosclerosis as young adults. The primary defect is a deficiency of apoprotein of VLDL, and the disorder is divided into two classes: 1) type IIA, which has elevated LDL due to a deficiency of the receptor or a modified apolipoprotein B-100; 2) type IIB, which has elevated LDL and triglycerides; autosomal dominant inheritance.
Synonym: familial hyperbetalipoproteinaemia, familial hypercholesteraemic xanthomatosis, familial hypercholesterolaemia.
(05 Mar 2000)
biliary xanthomatosis Xanthomatosis with hypercholesterolaemia, resulting from biliary cirrhosis.
Synonym: Rayer's disease.
(05 Mar 2000)
cerebrotendinous xanthomatosis A disorder with deposition of cholestanol in the brain and other tissues and high levels in plasma but with normal cholesterol level; characterised by progressive cerebellar ataxia beginning after puberty, juvenile cataracts, spinal cord involvement, and tendinous or tuberous xanthomata; autosomal recessive inheritance. Probably due to a defect in hepatic mitochondrial 26-hydroxylase in bile acid biosynthesis.
Synonym: cerebrotendinous cholesterinosis.
(05 Mar 2000)
chronic idiopathic xanthomatosis Vague or indefinite term for inherited abnormalities of lipid metabolism leading to xanthoma formation (e.g., primary familial xanthomatosis).
(05 Mar 2000)
Wolman's xanthomatosis A rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase. It results in an accumulation of neutral lipids, particularly cholesterol esters, within cells (particularly leukocytes, fibroblasts, and liver cells). It is an allelic variant of wolman disease.
(12 Dec 1998)
xanthomatosis <dermatology, pathology> An accumulation of an excess of lipids in the body due to disturbance of lipid metabolism and marked by the formation of foam cells in skin lesions.
(16 Dec 1997)
xanthomatosis bulbi Ulcerative fatty degeneration of the cornea after injury.
(05 Mar 2000)
xanthomatosis, cerebrotendinous A lipid storage disease, inherited as an autosomal recessive trait, characterised by xanthomas of the tendons, the white matter of the brain, and the lungs, and by spasticity, ataxia, pyramidal paresis, mental retardation, dementia, early cataracts, and atherosclerosis. It is associated with elevated plasma and tissue levels of cholestanol and defective bile synthesis, with the deposition of cholestanol in the central nervous system and myelin of peripheral nerves. The lesions contain cholesterol and dehydrocholesterol.
(12 Dec 1998)
normal cholesteraemic xanthomatosis histiocytosis
benign familial chorea A rare, nonprogressive movement disorder characterised by chorea and athetosis appearing in early childhood, most commonly manifested as gait ataxia and upper limb coordination. Intellect is unaffected. Probably autosomal-dominance inheritance with incomplete penetrance.
(05 Mar 2000)
benign familial chronic pemphigus Recurrent eruption of vesicles and bullae that become scaling and crusted lesions with vesicular borders, predominantly of the neck, groin, and axillary regions; autosomal dominant inheritance, presenting in late adolescence or early adult life.
Synonym: Hailey-Hailey disease.
(05 Mar 2000)
benign familial icterus Mild jaundice due to increased amounts of unconjugated bilirubin in the plasma without evidence of liver damage, biliary obstruction, or haemolysis; thought to be due to an inborn error of metabolism in which the excretion of bilirubin by the liver is defective, ascribed to decreased conjugation of bilirubin as a glucuronide or impaired uptake of hepatic bilirubin.
Synonym: benign familial icterus, constitutional hepatic dysfunction, Gilbert's disease, Gilbert's syndrome, Hebra's disease.
(05 Mar 2000)
cancer, breast, familial A number of factors have been identified that increase the risk of breast cancer. One of the strongest of these risk factors is the history of breast cancer in a relative. About 15-20% of women with breast cancer have such a family history of the disease, clearly reflecting the participation of inherited (genetic) components in the development of some breast cancers. Dominant breast cancer suceptibility genes, including BRCA1 and BRCA2, appear responsible for about 5% of all breast cancer.
(12 Dec 1998)
paralysis, familial periodic An autosomal dominant trait marked by recurring attacks of rapidly progressive flaccid paralysis. There are three types: I, associated with a fall in serum potassium levels (hypokalaemic periodic paralysis); II, associated with a rise therein (hyperkalaemic periodic paralysis, called also adynamia episodica hereditaria); and III, with normal levels (normokalaemic periodic paralysis).
(12 Dec 1998)
pemphigus, benign familial Rare hereditary disease characterised by recurrent eruptions of vesicles and bullae mainly on the neck, axillae, and groin. It exhibits autosomal dominant inheritance and is unrelated to pemphigus vulgaris though it closely resembles that disease.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial
    °¡Á·ÀÇ;°¡Á·¼ºÀÇ;°¡Á· ƯÀ¯ÀÇ
  • primary
    Áß¿äÇÑ
  • closed primary
    Á¦ÇÑ ¿¹ºñ ¼±°Å(´ç¿ø À¯ÀÚ°ÝÀÚ¸¸ÀÌ ÅõÇ¥ÇÏ´Â Èĺ¸ÀÚ ¼±°Å)
  • dircct primary
    Á÷Á¢ ¿¹¼±
  • indirect primary
    (¹Ì)°£Á¢ ¿¹ºñ ¼±°Å
  • open primary
    °ø°³ ¿¹¼± ´ëȸ
  • presidential primary
    (°¢ Á¤´çÀÇ)´ëÅë·É ¼±°ÅÀÎ ¿¹¼±È¸
  • primary
    ÃÖÃÊÀÇ;¿ø½ÃÀûÀÎ;¼öÀ§ÀÇ;ÁÖ¿äÇÑ;º»·¡ÀÇ;±Ùº»ÀÇ;Ãʺ¸ÀÇ;Á¦ 1±âÀÇ;1Â÷ÀÇ-Á¦ 1À§ÀÇ »ç¹°;¿ø»ö;ÀÏÂ÷¾î(¸í»ç »ó´ç ¾î±¸);´ëÅë·É Èĺ¸ ¿¹ºñ ¼±°Å
  • primary accent
    Á¦ ÀÏÀÇ ¾Ç¼¾Æ®
  • primary assembly
    ¿¹¼± ´ëȸ;»çÀü ÇùÀÇȸ
  • primary atypical pneumonia
    1Â÷¼º ºñÁ¤Çü Æó·Å
  • primary care
    ÀÏÂ÷ ÀÇ·á(ÀÀ±Þ Ä¡·á µî ÁÖ°ÅÁö¿¡¼­ ÇàÇÏ´Â Ãʱâ ÀÇ·á)
  • primary cell
    1Â÷ ÀüÁö
  • primary coil
    1Â÷ ÄÚÀÏ
  • primary colors
    ¿ø»ö(»¡°­,³ë¶û,ÆÄ¶û)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á